Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Synthetic Blood International, Inc. (SYBD) -- Ignore unavailable to you. Want to Upgrade?

To: taylorfife who wrote (63)	5/24/1999 9:28:00 AM
From: StandFast	Respond to of 91

JMO, but this doesn't help, short term. Long term it will eventually be absorbed.

To: taylorfife who wrote (63)	5/24/1999 10:35:00 AM
From: Micro-Selector	Read Replies (1) \| Respond to of 91

IMO, this is great news! It shows SYBD is right on track. This new stock will be used to help secure future financing for product development and clinical trials. "Private and institutional investors have expressed interest in financing further development of our products up to the corporate partner stage," said Robert Nicora, SYBD president. "The ability to issue preferred, convertible stock will aid in securing this financing without diluting existing common stock." Approval to issue preferred stock does not affect plans for a current, private placement which is expected to result in an announcement soon. Rather, it will be used to secure additional funding in the future.